Global Tissue Banking Equipment Market Size By Type (Freezers, Storage System), By Application (Hospitals, Tissue Banks), By Region, And Segment Forecasts, 2023 to 2032

The Global Tissue Banking Equipment Market was valued at USD 1.1 billion in 2023 and is projected to reach USD 1.9 billion by 2031, growing at a CAGR of 6.9% during the forecast period from 2023 to 2031. Tissue banking equipment plays a critical role in the preservation, storage, and management of human tissues for therapeutic, research, and clinical applications. The growth of the market is fueled by rising demand for regenerative medicine, an increasing number of tissue-based research activities, and advancements in biobanking technologies.

As healthcare institutions and research organizations expand their focus on personalized medicine, the demand for efficient, contamination-free, and regulatory-compliant tissue banking systems continues to grow globally.

Drivers:

1. Growing Demand for Regenerative Medicine:

Tissue banking supports the long-term storage of viable cells and tissues used in regenerative therapies. The rapid development in stem cell research and tissue engineering is significantly boosting the need for advanced equipment capable of maintaining biological integrity.

2. Advancements in Biopreservation Technologies:

Continuous innovations in cryopreservation, controlled-rate freezers, and storage units have made it easier to store and manage human tissues with minimal degradation, which is encouraging the adoption of modern tissue banking systems.

3. Increasing Organ and Tissue Transplantation Procedures:

With rising cases of chronic diseases and trauma-related injuries, there is a growing number of organ and tissue transplant procedures worldwide. This has directly influenced the demand for effective tissue storage and tracking systems.

Restraints:

1. High Capital Investment and Maintenance Costs:

Setting up and maintaining a tissue bank involves significant investment in high-end equipment, temperature control systems, and skilled personnel. These high costs can limit adoption, especially in resource-constrained regions.

2. Stringent Regulatory Requirements:

Tissue banking is subject to strict regulatory and ethical standards that vary across countries. Compliance with these frameworks often requires time-consuming approvals and may delay equipment deployment.

Opportunity:

1. Rising Investments in Biobanking Infrastructure in Emerging Markets:

Emerging economies in Asia-Pacific and Latin America are investing heavily in life sciences and clinical research, creating substantial opportunities for the expansion of tissue banking infrastructure.

2. Integration of Digital Monitoring and Automation:

The integration of IoT, cloud-based data management, and automation in tissue banking equipment is streamlining operations and enhancing the traceability of biological samples, paving the way for next-generation solutions.

Market by System Type Insights:

The Freezers & Storage Systems segment dominated the market in 2023, accounting for the largest revenue share. These systems ensure stable ultra-low temperatures for long-term tissue preservation and are indispensable to any tissue banking facility. However, the Automated Storage and Retrieval Systems segment is anticipated to witness the fastest growth during the forecast period, driven by the need for higher efficiency and reduced human error.

Market by End-Use Insights:

By end-use, the Hospitals and Transplant Centers segment held the majority share in 2023. These facilities are on the frontline of organ and tissue transplantation procedures and require advanced equipment for compliance and safety. Meanwhile, the Biobanks and Research Laboratories segment is expected to grow significantly, fueled by increasing biomedical research and drug discovery efforts.

Market by Regional Insights:

North America led the global tissue banking equipment market in 2023 due to its established biobanking infrastructure, advanced healthcare systems, and strong government funding for biomedical research. However, Asia-Pacific is projected to grow at the highest CAGR during the forecast period. Factors such as increasing investments in healthcare infrastructure, rising awareness, and growing participation in global clinical trials are contributing to this growth.

Competitive Scenario:

Key players in the global tissue banking equipment market include:

Thermo Fisher Scientific Inc.

Brooks Life Sciences

PHC Holdings Corporation (Panasonic Healthcare)

BioLife Solutions, Inc.

Custom Biogenic Systems

Hamilton Company

Avantor, Inc.

LabVantage Solutions, Inc.

Worthington Industries, Inc.

Tecan Group Ltd.

These companies are actively involved in strategic partnerships, product innovation, and geographical expansion to strengthen their market presence. For instance:

In 2023, Thermo Fisher Scientific launched a new series of high-capacity ultra-low temperature freezers with energy-efficient technologies.

In 2024, BioLife Solutions introduced AI-driven monitoring solutions for tissue banking environments to enhance operational reliability and compliance.

Scope of Work – Global Tissue Banking Equipment Market

Report Metric Details

Market Size (2023) USD 1.1 billion

Projected Market Size (2031) USD 1.9 billion

CAGR (2023–2031) 6.9%

Key Segments by System Type Freezers & Storage Systems, Cryopreservation Equipment, Automated Storage

Key Segments by End-Use Hospitals & Transplant Centers, Biobanks, Research Laboratories

Leading Region North America

Key Players Thermo Fisher Scientific, PHC Holdings, BioLife Solutions, Brooks Life Sciences

Market Drivers Growth in regenerative medicine, rising transplants, technological innovations

Market Opportunities Automation and IoT integration, emerging markets expansion

Key Market Developments:

August 2023: PHC Holdings introduced compact cryogenic freezers targeting small- to medium-scale tissue banking labs.

January 2024: Hamilton Company expanded its automated tissue sample storage system lineup with advanced robotic handling.

March 2024: BioLife Solutions acquired a digital monitoring startup to enhance real-time temperature and humidity tracking across biobank facilities.

FAQs:

1. What is the current market size of the Global Tissue Banking Equipment Market?

The market size in 2023 was valued at USD 1.1 billion.

2. What is the major growth driver of the Global Tissue Banking Equipment Market?

The increasing demand for regenerative medicine and advancements in biopreservation technologies are major growth drivers.

3. Which is the largest region during the forecast period in the Global Tissue Banking Equipment Market?

North America holds the largest market share, with Asia-Pacific projected to grow at the fastest pace.

4. Which segment accounted for the largest market share in the Global Tissue Banking Equipment Market?

The Freezers & Storage Systems segment accounted for the largest share by system type in 2023.

5. Who are the key market players in the Global Tissue Banking Equipment Market?

Key players include Thermo Fisher Scientific, BioLife Solutions, PHC Holdings, and Brooks Life Sciences.